Xue Qin, Patterson Andrew J, Xiao Daliao, Zhang Lubo
Center for Perinatal Biology, Division of Pharmacology, Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, California, United States of America.
PLoS One. 2014 Sep 29;9(9):e106827. doi: 10.1371/journal.pone.0106827. eCollection 2014.
Glucocorticoid regulates angiotensin II receptor (ATR) expression via activating glucocorticoid receptors and binding to glucocorticoid response elements. The regulation of ATR by glucocorticoids in the context of myocardial injury from ischemia/reperfusion (I/R) is yet to be elucidated. The present study determined the role of ATR in glucocorticoid-induced cardiac protection. Adult male rats were administered once a day i.p. 1 mg/kg/day dexamethasone or dexamethasone plus 10 mg/kg/day RU486 for 5 days. Hearts were then isolated and subjected to I/R injury in a Langendorff preparation. Dexamethasone treatment significantly decreased I/R injury and improved post-ischemic recovery of cardiac function. Dexamethasone increased glucocorticoid receptor binding to glucocorticoid response elements at AT1aR and AT2R promoters, resulting in a significant increase in expression of AT1R protein but a decrease in AT2R expression in the heart. In addition, dexamethasone treatment significantly increased PKCε expression and p-PKCε protein abundance. These dexamethasone-mediated effects were blocked by RU486. More importantly, blockade of AT1R and AT2R with losartan and PD123319 abrogated dexamethasone-induced protection of the heart from I/R injury. The results indicate that glucocorticoid promotes a cardioprotective phenotype associated with the upregulation of AT1R and PKCε and downregulation of AT2R in the heart.
糖皮质激素通过激活糖皮质激素受体并结合糖皮质激素反应元件来调节血管紧张素 II 受体(ATR)的表达。在缺血/再灌注(I/R)引起的心肌损伤背景下,糖皮质激素对 ATR 的调节作用尚待阐明。本研究确定了 ATR 在糖皮质激素诱导的心脏保护中的作用。成年雄性大鼠每天腹腔注射一次 1 mg/kg/天的地塞米松或地塞米松加 10 mg/kg/天的 RU486,持续 5 天。然后分离心脏,并在 Langendorff 装置中进行 I/R 损伤。地塞米松治疗显著降低了 I/R 损伤,并改善了缺血后心脏功能的恢复。地塞米松增加了糖皮质激素受体与 AT1aR 和 AT2R 启动子处糖皮质激素反应元件的结合,导致心脏中 AT1R 蛋白表达显著增加,但 AT2R 表达减少。此外,地塞米松治疗显著增加了 PKCε 的表达和 p-PKCε 蛋白丰度。这些地塞米松介导的效应被 RU486 阻断。更重要的是,用氯沙坦和 PD123319 阻断 AT1R 和 AT2R 消除了地塞米松对心脏 I/R 损伤的保护作用。结果表明,糖皮质激素促进了一种心脏保护表型,其与心脏中 AT1R 和 PKCε 的上调以及 AT2R 的下调有关。